Cargando…

Structure of the Inhibited State of the Sec Translocon

Protein secretion in eukaryotes and prokaryotes involves a universally conserved protein translocation channel formed by the Sec61 complex. Unrelated small-molecule natural products and synthetic compounds inhibit Sec61 with differential effects for different substrates or for Sec61 from different o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gérard, Samuel F., Hall, Belinda S., Zaki, Afroditi M., Corfield, Katherine A., Mayerhofer, Peter U., Costa, Catia, Whelligan, Daniel K., Biggin, Philip C., Simmonds, Rachel E., Higgins, Matthew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427319/
https://www.ncbi.nlm.nih.gov/pubmed/32692975
http://dx.doi.org/10.1016/j.molcel.2020.06.013
_version_ 1783570855626801152
author Gérard, Samuel F.
Hall, Belinda S.
Zaki, Afroditi M.
Corfield, Katherine A.
Mayerhofer, Peter U.
Costa, Catia
Whelligan, Daniel K.
Biggin, Philip C.
Simmonds, Rachel E.
Higgins, Matthew K.
author_facet Gérard, Samuel F.
Hall, Belinda S.
Zaki, Afroditi M.
Corfield, Katherine A.
Mayerhofer, Peter U.
Costa, Catia
Whelligan, Daniel K.
Biggin, Philip C.
Simmonds, Rachel E.
Higgins, Matthew K.
author_sort Gérard, Samuel F.
collection PubMed
description Protein secretion in eukaryotes and prokaryotes involves a universally conserved protein translocation channel formed by the Sec61 complex. Unrelated small-molecule natural products and synthetic compounds inhibit Sec61 with differential effects for different substrates or for Sec61 from different organisms, making this a promising target for therapeutic intervention. To understand the mode of inhibition and provide insight into the molecular mechanism of this dynamic translocon, we determined the structure of mammalian Sec61 inhibited by the Mycobacterium ulcerans exotoxin mycolactone via electron cryo-microscopy. Unexpectedly, the conformation of inhibited Sec61 is optimal for substrate engagement, with mycolactone wedging open the cytosolic side of the lateral gate. The inability of mycolactone-inhibited Sec61 to effectively transport substrate proteins implies that signal peptides and transmembrane domains pass through the site occupied by mycolactone. This provides a foundation for understanding the molecular mechanism of Sec61 inhibitors and reveals novel features of translocon function and dynamics.
format Online
Article
Text
id pubmed-7427319
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-74273192020-08-16 Structure of the Inhibited State of the Sec Translocon Gérard, Samuel F. Hall, Belinda S. Zaki, Afroditi M. Corfield, Katherine A. Mayerhofer, Peter U. Costa, Catia Whelligan, Daniel K. Biggin, Philip C. Simmonds, Rachel E. Higgins, Matthew K. Mol Cell Article Protein secretion in eukaryotes and prokaryotes involves a universally conserved protein translocation channel formed by the Sec61 complex. Unrelated small-molecule natural products and synthetic compounds inhibit Sec61 with differential effects for different substrates or for Sec61 from different organisms, making this a promising target for therapeutic intervention. To understand the mode of inhibition and provide insight into the molecular mechanism of this dynamic translocon, we determined the structure of mammalian Sec61 inhibited by the Mycobacterium ulcerans exotoxin mycolactone via electron cryo-microscopy. Unexpectedly, the conformation of inhibited Sec61 is optimal for substrate engagement, with mycolactone wedging open the cytosolic side of the lateral gate. The inability of mycolactone-inhibited Sec61 to effectively transport substrate proteins implies that signal peptides and transmembrane domains pass through the site occupied by mycolactone. This provides a foundation for understanding the molecular mechanism of Sec61 inhibitors and reveals novel features of translocon function and dynamics. Cell Press 2020-08-06 /pmc/articles/PMC7427319/ /pubmed/32692975 http://dx.doi.org/10.1016/j.molcel.2020.06.013 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gérard, Samuel F.
Hall, Belinda S.
Zaki, Afroditi M.
Corfield, Katherine A.
Mayerhofer, Peter U.
Costa, Catia
Whelligan, Daniel K.
Biggin, Philip C.
Simmonds, Rachel E.
Higgins, Matthew K.
Structure of the Inhibited State of the Sec Translocon
title Structure of the Inhibited State of the Sec Translocon
title_full Structure of the Inhibited State of the Sec Translocon
title_fullStr Structure of the Inhibited State of the Sec Translocon
title_full_unstemmed Structure of the Inhibited State of the Sec Translocon
title_short Structure of the Inhibited State of the Sec Translocon
title_sort structure of the inhibited state of the sec translocon
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427319/
https://www.ncbi.nlm.nih.gov/pubmed/32692975
http://dx.doi.org/10.1016/j.molcel.2020.06.013
work_keys_str_mv AT gerardsamuelf structureoftheinhibitedstateofthesectranslocon
AT hallbelindas structureoftheinhibitedstateofthesectranslocon
AT zakiafroditim structureoftheinhibitedstateofthesectranslocon
AT corfieldkatherinea structureoftheinhibitedstateofthesectranslocon
AT mayerhoferpeteru structureoftheinhibitedstateofthesectranslocon
AT costacatia structureoftheinhibitedstateofthesectranslocon
AT whelligandanielk structureoftheinhibitedstateofthesectranslocon
AT bigginphilipc structureoftheinhibitedstateofthesectranslocon
AT simmondsrachele structureoftheinhibitedstateofthesectranslocon
AT higginsmatthewk structureoftheinhibitedstateofthesectranslocon